YU17002A - Upotreba deksrazoksana u lečenju psorijaze - Google Patents

Upotreba deksrazoksana u lečenju psorijaze

Info

Publication number
YU17002A
YU17002A YU17002A YUP17002A YU17002A YU 17002 A YU17002 A YU 17002A YU 17002 A YU17002 A YU 17002A YU P17002 A YUP17002 A YU P17002A YU 17002 A YU17002 A YU 17002A
Authority
YU
Yugoslavia
Prior art keywords
psoriasis
dextrazohane
healing
dioxopiperazin
dexrazoxane
Prior art date
Application number
YU17002A
Other languages
English (en)
Inventor
Iervant Zarmanian
Jadranka Rogan-Grgas
Original Assignee
Cyathus Exquirere Pharmaforschungs Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyathus Exquirere Pharmaforschungs Gmbh. filed Critical Cyathus Exquirere Pharmaforschungs Gmbh.
Publication of YU17002A publication Critical patent/YU17002A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Upotreba deksrazoksana, d-izomera 1,2-bis(3,5-dioksopiperazin-1-il)-propana ili njene fiziološki prihvatljive soli u proizvodnji leka za lečenje psorijaze.[The use for the manufacture of a medicament for treating psoriasis of dexrazoxane, the d-isomer of 1,2-bis(3,5-dioxopiperazin-1-yl)- propane, or a physiologically acceptable salt thereof.
YU17002A 1999-09-10 2000-09-08 Upotreba deksrazoksana u lečenju psorijaze YU17002A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT155899 1999-09-10
US18380600P 2000-02-22 2000-02-22

Publications (1)

Publication Number Publication Date
YU17002A true YU17002A (sh) 2004-11-25

Family

ID=30773863

Family Applications (1)

Application Number Title Priority Date Filing Date
YU17002A YU17002A (sh) 1999-09-10 2000-09-08 Upotreba deksrazoksana u lečenju psorijaze

Country Status (2)

Country Link
US (1) US6693100B1 (sh)
YU (1) YU17002A (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9011934B2 (en) 2013-06-14 2015-04-21 SatisPharma, LLC Multi-purpose anti-itch treatment
US9452178B1 (en) 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941790A (en) 1967-07-03 1976-03-02 National Research Development Corporation Bis diketopiperazines
GB1234935A (en) 1967-07-03 1971-06-09 Nat Res Dev Piperazine derivatives
US4963679A (en) 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
CA2167805A1 (en) 1993-07-23 1995-02-02 L. David Tomei Methods of treating apoptosis and associated conditions

Also Published As

Publication number Publication date
US6693100B1 (en) 2004-02-17

Similar Documents

Publication Publication Date Title
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
GB0223038D0 (en) Therapeutic compounds
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
SE9802208D0 (sv) Novel compounds
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
CA2176298A1 (en) A single high dose fluoroquinolone treatment
ZA988095B (en) New peptide mimetics for the treatment of bone metabolic disorders, methods for their production, and drugs containing these compounds.
AU3598299A (en) Improved compositions for inhalation
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
SE9802209D0 (sv) Novel compounds
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
BG105204A (en) Salts of paroxetine
YU17002A (sh) Upotreba deksrazoksana u lečenju psorijaze
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
BG106428A (en) Pharmaceutical compositions for treating psoriasis
ZA9711719B (en) Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
BG105289A (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-pip eridinemethanol for the treatment of sleep disorders